HighTower Advisors
IBRX icon

HighTower Advisors’s ImmunityBio IBRX Stock Holding History

HighTower Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$429K Buy
55,880
+22,368
+67% +$153K ﹤0.01% 2854
2025
Q4 		$66.4K Sell
33,512
-13,549
-29% -$30.7K ﹤0.01% 3554
2025
Q3 		$116K Buy
47,061
+13,287
+39% +$34.2K ﹤0.01% 3514
2025
Q2 		$89.2K Buy
33,774
+2,565
+8% +$6.9K ﹤0.01% 3488
2025
Q1 		$93.9K Buy
31,209
+1,114
+4% +$3.38K ﹤0.01% 3374
2024
Q4 		$77K Sell
30,095
-6,517
-18% -$27.1K ﹤0.01% 3415
2024
Q3 		$136K Buy
+36,612
New +$169K ﹤0.01% 3242
2024
Q2 		– Sell
-10,302
Closed -$55K – 3797
2024
Q1 		$55K Buy
+10,302
New +$46.6K ﹤0.01% 3242

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return